A multicenter, open-label, randomized, phase III study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab versus treatment of physician's choice in patients with advanced endometrial cancerVicky Makker,Nicoletta Colombo,Antonio Casado Herraez,Alessandro Santin,Emeline Colomba,David Miller,Keiichi Fujiwara,Sandro Pignata,Sally Baron-Hay,Isabelle Ray-Coquard,Ronnie Shapira-Frommer,Kimio Ushijima,Jun Sakata,Kan Yonemori,Yong Man Kim,Eva Guerra,Ulus Sanli,Mary Mccormack,Jie Huang,Alan Smith,Stephen Keefe,Lea Dutta,Robert Orlowski,Domenica LorussoGynecologic Oncology(2021)引用 44|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要